债务 更改
AbbVie USD 72.86B 5.36B 2026-03
Align Technology USD 116.04M 1.6M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Coherus Biosciences USD 294.92M 1.25M 2025-03
Dentsply International USD 2.33B 137M 2026-03
Eli Lilly USD 42.5B 3.6M 2025-12
Henry Schein USD 3.75B 313M 2026-03
Idexx Laboratories USD 1.11B 129.39M 2026-03
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
J&J USD 54.99B 7.05B 2026-03
Laboratory Of America USD 7.24B 714.6M 2026-03
Merck USD 49.34B 7.97B 2025-12
Neogen USD 793.3M 374K 2025-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pfizer USD 63.73B 231M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Quest Diagnostics USD 6.41B 179M 2026-03
Sanofi EUR 23.58B 3.56B 2026-06
Sanofi EUR 20.02B 1.73B 2026-03
Zoetis USD 9.24B 1.96B 2025-12